Aster DM Quality Care · NSE: ASTERDM · BSE: 540975

Q4 FY24 results · Jan–Mar 2024

Aster DM Quality Care reported revenue from operations of ₹973.59 crore (down 70.2% from Q4 FY23) and net loss of ₹2.17 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations973.593,262.32−70.2%3,710.61−73.8%
Other income4.0814.03−70.9%7.95−48.7%
Total income977.673,276.35−70.2%3,718.56−73.7%
Profit before share of associates & JVs and tax75.18205.05−63.3%241.91−68.9%
Share of profit/(loss) of associates & JVs(2.86)0.73(8.45)
Net profit for the period(2.17)182.59Turned loss209.22Turned loss
Attributable to shareholders of the company(24.03)170.77Turned loss179.21Turned loss
EPS, basic (₹)(0.48)3.43Turned loss3.60Turned loss
Net margin (%)-0.25.65.6

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations545.56429.46+27.0%524.50+4.0%
Other income3.7212.23−69.6%13.33−72.1%
Total income549.28441.69+24.4%537.83+2.1%
Profit before tax46.6554.05−13.7%53.19−12.3%
Net profit for the period(8.11)51.87Turned loss53.19Turned loss
EPS, basic (₹)(0.16)1.04Turned loss1.07Turned loss
Net margin (%)-1.512.110.1
Consolidated
Filed with BSE
29 May 2024, 17:28 IST
Board meeting
28 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
29 May 2024, 17:28 IST
Board meeting
28 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Audited
Source
XBRL filing on BSE